journal article·2021-09-28Open access

Theranostic Advances of Bionanomaterials against Gestational Diabetes Mellitus: A Preliminary Review

Mahmood Barani, Saman Sargazi, Vahideh Mohammadzadeh, Abbas Rahdar, Sadanand Pandey, Niraj Kumar Jha, Piyush Kumar Gupta, Vijay Kumar Thakur

Abstract

Gestational diabetes mellitus (GDM) is the most frequent complication during pregnancy. This complex disease is characterized by glucose intolerance and consequent hyperglycemia that begins or is first diagnosed in pregnancy, and affects almost 7% of pregnant women. Previous reports have shown that GDM is associated with increased pregnancy complications and might cause abnormal fetal development. At present, treatments are not suitable for the prevention and management of these patients. As an alternative therapeutic opportunity and a leading scientific technique, nanotechnology has helped enlighten the health of these affected women. Theranostic nanomaterials with unique properties and small sizes (at least <100 nm in one of their dimensions) have been recently engineered for clinics and pharmaceutics. Reducing materials to the nanoscale has successfully changed their properties and enabled them to uniquely interact with cell biomolecules. Several biosensing methods have been developed to monitor glucose levels in GDM patients. Moreover, cerium oxide nanoparticles (NPs), selenium NPs, polymeric NPs, and drug-loaded NPs loaded with therapeutic agents have been used for GDM treatment. Still, there are some challenges associated with the detection limits and toxicity of such nanomaterials. This preliminary review covers the aspects from a fast-developing field to generating nanomaterials and their applications in GDM diagnosis and treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Infant Nutrition and Health · Graphene and Nanomaterials Applications · COVID-19 Impact on Reproduction

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman 7616913555, Iran

Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan 9816743463, Iran

Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Science, Mashhad 1313199137, Iran

Department of Physics, Faculty of Science, University of Zabol, Zabol 53898615, Iran

Department of Chemistry, College of Natural Science, Yeungnam University, 280 Daehak-ro, Gyeongsan 38541, Gyeongbuk, Korea

Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida 201310, India

Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Greater Noida 201310, India

Biorefining and Advanced Materials Research Centre, SRUC, Edinburgh EH9 3JG, UK

Department of Mechanical Engineering, School of Engineering, Shiv Nadar University, Noida 201314, India

School of Engineering, University of Petroleum & Energy Studies (UPES), Dehradun 248007, India

References (91)

Show source-provided references
1. Epidemiology of diabetes mellitus and cardiovascular disease10.1007/s11886-019-1107-y ↗
2. Diabetes mellitus statistics on prevalence and mortality: Facts and fallacies10.1038/nrendo.2016.105 ↗
3. Gestational diabetes mellitus in India
4. Gestational diabetes mellitus
5. The hyperglycemia and adverse pregnancy outcome study: Associations of GDM and obesity with pregnancy outcomes10.2337/dc11-1790 ↗
6. American Diabetes Association (2003). Gestational diabetes mellitus. Diabetes Care, 26, S103–S105.10.2337/diacare.26.2007.S103 ↗
7. Hyperglycemia and adverse pregnancy outcomes10.1056/NEJMoa0707943 ↗
8. Gestational diabetes mellitus: Mechanisms, treatment, and complications10.1016/j.tem.2018.09.004 ↗
9. Increasing prevalence of gestational diabetes mellitus: A public health perspective10.2337/dc07-s206 ↗
10. Current practices in the diagnosis and management of gestational diabetes mellitus in India (WINGS-5)10.4103/2230-8210.180001 ↗
11. Nelson, R.L. (1988). Oral glucose tolerance test: Indications and limitations. Mayo Clinic Proceedings, Elsevier.10.1016/S0025-6196(12)62372-6 ↗
12. Gestational diabetes mellitus: An update on the current international diagnostic criteria10.4239/wjd.v6.i6.782 ↗
13. Advertising Association (2018). Management of diabetes in pregnancy: Standards of Medical Care in Diabetes—2018. Diabetes Care, 41, S137–S143.10.2337/dc18-S013 ↗
14. Metformin versus insulin for the treatment of gestational diabetes10.1056/NEJMoa0707193 ↗
15. Prevalence of gestational diabetes mellitus in Europe: A meta-analysis10.1016/j.diabres.2017.03.030 ↗
16. Nanomedical Devices and Cancer Theranostics10.2174/2666150002006010001 ↗
17. Chemistry, Structures, and Advanced Applications of Nanocomposites from Biorenewable Resources10.1021/acs.chemrev.9b00553 ↗
18. Gold nanoparticle-mediated bubbles in cancer nanotechnology
19. Shakeri, S., Ashrafizadeh, M., Zarrabi, A., Roghanian, R., Afshar, E.G., Pardakhty, A., Mohammadinejad, R., Kumar, A., and Thakur, V.K. (2020). Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics. Biomedicines, 8.10.3390/biomedicines8010013 ↗
20. Nanosensors and nanomaterials for monitoring glucose in diabetes10.1016/j.molmed.2010.08.002 ↗
21. Antibacterial and Antiviral Functional Materials: Chemistry and Biological Activity toward Tackling COVID-19-like Pandemics10.1021/acsptsci.0c00174 ↗
22. Cerium oxide nanoparticles: Green synthesis using Banana peel, cytotoxic effect, UV protection and their photocatalytic activity10.1007/s00449-021-02569-9 ↗
23. Nickel-doped cerium oxide nanoparticles: Biosynthesis, cytotoxicity and UV protection studies10.1039/C9RA09076B ↗
24. Biosynthesis of lead oxide and cerium oxide nanoparticles and their cytotoxic activities against colon cancer cell line10.1016/j.inoche.2021.108800 ↗
25. Long-term glycemic control and prevention of diabetes complications in vivo using oleic acid-grafted-chitosan-zinc-insulin complexes incorporated in thermosensitive copolymer10.1016/j.jconrel.2020.04.012 ↗
26. Prophylactic Oral Administration of Metabolically Active Insulin Entrapped in Isobutylcyanoacrylate Nanocapsules Reduces the Incidence of Diabetes inNonobese DiabeticMice10.1006/jaut.1996.0093 ↗
27. Titania Modified Gum Tragacanth Based Hydrogel Nanocomposite for Water Remediation10.1016/j.jece.2020.104608 ↗
28. Bioadhesive chitosan-coated cationic nanoliposomes with improved insulin encapsulation and prolonged oral hypoglycemic effect in diabetic mice10.1016/j.xphs.2018.04.011 ↗
29. Enhanced and selective acetone sensing properties of SnO2-MWCNT nanocomposites: Promising materials for diabetes sensor10.1016/j.matdes.2016.11.042 ↗
30. Preparation of exosomes encapsulated nanohydrogel for accelerating wound healing of diabetic rats by promoting angiogenesis10.1016/j.msec.2020.111671 ↗
31. Nanoparticulate drug delivery systems for the treatment of diabetes
32. Molecular prospect of type-2 diabetes: Nanotechnology based diagnostics and therapeutic intervention10.1007/s11154-020-09606-0 ↗
33. Engineering periplasmic ligand binding proteins as glucose nanosensors10.3402/nano.v2i0.5743 ↗
34. Wang, L., Yun, X., Stanacevic, M., and Gouma, P. (2009). An Acetone Nanosensor For Non-invasive Diabetes Detection. Aip Conference Proceedings, American Institute of Physics.10.1063/1.3156509 ↗
35. Near-infrared optical nanosensors for continuous detection of glucose10.1177/1932296819886928 ↗
36. Copolymer-Based Fluorescence Nanosensor for In Situ Imaging of Homocysteine in the Liver and Kidney of Diabetic Mice10.1021/acs.analchem.0c04068 ↗
37. An integrated flexible and reusable graphene field effect transistor nanosensor for monitoring glucose
38. Synthesis of silver nanoparticles using muntingia calabura L. Leaf extract as bioreductor and applied as glucose nanosensor10.13005/ojc/340652 ↗
39. Cancer nanotechnology: A new revolution for cancer diagnosis and therapy10.2174/1389200219666180918111528 ↗
40. Recent advances on nanomaterial based electrochemical and optical aptasensors for detection of cancer biomarkers10.1016/j.trac.2017.12.019 ↗
41. Biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin10.1080/10717544.2020.1775722 ↗
42. Screening for biomarkers predictive of gestational diabetes mellitus10.1007/s00592-008-0037-8 ↗
43. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks10.1002/pd.2636 ↗
44. Rodrigo, N., and Glastras, S.J. (2018). The emerging role of biomarkers in the diagnosis of gestational diabetes mellitus. J. Clin. Med., 7.10.3390/jcm7060120 ↗
45. Bogdanet, D., Reddin, C., Murphy, D., Doheny, H.C., Halperin, J.A., Dunne, F., and O’Shea, P.M. (2021). Emerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes—A Scoping Review. J. Clin. Med., 10.10.3390/jcm10071533 ↗
46. Intended and unintended pregnancies worldwide in 2012 and recent trends10.1111/j.1728-4465.2014.00393.x ↗
47. Glycemic level at the first visit and prediction of GDM
48. Recent trends in diabetes treatment using nanotechnology
49. Applications of nanotechnology in diabetes
50. Glucose oxidase complexed gold-graphene nanocomposite on a dielectric surface for glucose detection: A strategy for gestational diabetes mellitus10.2147/IJN.S222238 ↗
51. Zheng, S., Zhang, H., Lakshmipriya, T., Gopinath, S.C., and Yang, N. (2019). Gold nanorod integrated electrochemical sensing for hyperglycaemia on interdigitated electrode. BioMed Res. Int., 2019.10.1155/2019/9726967 ↗
52. Chen, L., Xie, W., Luo, Y., Ding, X., Fu, B., Gopinath, S.C., and Xiong, Y. (2021). Sensitive silica-alumina modified capacitive non-faradaic glucose sensor for gestational diabetes. Biotechnol. Appl. Biochem.10.1002/bab.2155 ↗
53. A novel dual imprinted conducting nanocubes based flexible sensor for simultaneous detection of hemoglobin and glycated haemoglobin in gestational diabetes mellitus patients10.1016/j.snb.2019.01.093 ↗
54. Biomarkers in diabetes: Hemoglobin A1c, vascular and tissue markers10.1016/j.trsl.2012.01.009 ↗
55. Glycated albumin: A potential biomarker in diabetes10.1590/2359-3997000000272 ↗
56. Development of a colorimetric paper fluidic dipstick assay for measurement of glycated albumin to monitor gestational diabetes at the point-of-care10.1016/j.talanta.2020.121728 ↗
57. Simultaneous detection of serum glucose and glycated albumin on a paper-based sensor for acute hyperglycemia and diabetes mellitus10.1021/acs.analchem.0c02940 ↗
58. Proteomic-driven biomarker discovery in gestational diabetes mellitus: A review10.1016/j.jprot.2015.07.020 ↗
59. Ai, T., Chen, F., Zhou, S., Zhang, J., Zheng, H., Zhou, Y., Hu, W., Liu, X., Li, L., and Lin, J. (2015). Magnetic bead-based serum peptidome profiling in patients with gestational diabetes mellitus. BioMed Res. Int., 2015.10.1155/2015/586309 ↗
60. Sokup, S.J. (2012). ISOLATION of Urinary Epithelial Cell DNA for the Analysis of 4-Aminobiphenyl DNA Adducts by Nano-LC/ESI-MS/MS. [Master’s Thesis, Northeastern University].
61. What is gestational diabetes?10.2337/dc07-s201 ↗
62. Assessment of Major Complications in Pregnancy: A Single Center Study
63. Cerium oxide nanoparticle: A remarkably versatile rare earth nanomaterial for biological applications10.1038/am.2013.88 ↗
64. Korsvik, C., Patil, S., Seal, S., and Self, W.T. (2007). Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem. Commun., 1056–1058.10.1039/b615134e ↗
65. The role of cerium redox state in the SOD mimetic activity of nanoceria10.1016/j.biomaterials.2008.03.014 ↗
66. Seeing the benefits of ceria10.1038/nnano.2006.111 ↗
67. Protective Effect of nanoceria against streptozotocin induced mitochondrial dysfunction in embryo of diabetic mice
68. Neuroprotective effect of cerium oxide nanoparticles in a rat model of experimental diabetic neuropathy10.1016/j.brainresbull.2017.03.013 ↗
69. Selenium as a pleiotropic agent for medical discovery and drug delivery10.2147/IJN.S181343 ↗
70. Effects of selenium nanoparticles on kidney and liver functional disorders in streptozotocin-induced diabetic rats
71. Recent Advances in Graft Copolymerization and Applications of Chitosan: A Review10.1021/sc500634p ↗
72. Selenium nanoparticles mitigate diabetic nephropathy and pancreatopathy in rat offspring via inhibition of oxidative stress10.1016/j.jksus.2020.101265 ↗
73. Wang, Y., Cheng, S., Fan, W., Jiang, Y., Yang, J., Tong, Z., and Jiang, G. (2021). Dual responsive block copolymer coated hollow mesoporous silica nanoparticles for glucose-mediated transcutaneous drug delivery. Chin. J. Chem. Eng., in press.10.1016/j.cjche.2021.07.019 ↗
74. Dave, P.N., and Gor, A. (2018). Natural polysaccharide-based hydrogels and nanomaterials: Recent trends and their applications. Handb. Nanomater. Ind. Appl., 36–66.10.1016/B978-0-12-813351-4.00003-1 ↗
75. Novel greener approached synthesis of polyacrylic nanoparticles for therapy and care of gestational diabetes10.1080/10717544.2020.1809555 ↗
76. Conceivable Protective Role of Murraya koenigii Leaf Extract Loaded Poly (D, L-lactic-co-glycolic acid)-Gold-Nanoparticles on the Gestational Diabetes Mellitus of Rats Induced by Streptozotocin10.1166/sam.2020.3569 ↗
77. Managing diabetes with nanomedicine: Challenges and opportunities10.1038/nrd4477 ↗
78. Khalil, O.S. (2006). Non-Invasive Monitoring of Diabetes. Glucose Sensing, Springer.10.1007/0-387-33015-1_7 ↗
79. Nanotechnology in glucose monitoring: Advances and challenges in the last 10 years10.1016/j.bios.2013.02.043 ↗
80. Heterogeneity of insulin resistance and beta cell dysfunction in gestational diabetes mellitus: A prospective cohort study of perinatal outcomes10.1186/s12967-018-1666-5 ↗
81. Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation10.1021/nl080694q ↗
82. Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets10.1021/nl061049r ↗
83. A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets10.1016/j.surg.2004.05.031 ↗
84. Encapsulated cell technology10.1038/nbt0996-1107 ↗
85. Encapsulate this; these precious cells. A team of bioengineers thinks it has discovered one: Insulin-producing islet cells could hold the secret to curing type 1 diabetes—If only scientists could figure out a way to encapsulate and transplant them into the body. But first, the right biocompatible material must be found to hold10.1038/nm0114-9 ↗
86. Insights into the Synthesis and Mechanism of Green Synthesized Antimicrobial Nanoparticles, Answer to the Multidrug Resistance10.1016/j.mtchem.2020.100391 ↗
87. Nanomaterials for Theranostics: Recent Advances and Future Challenges10.1021/cr300213b ↗
88. Recent Progress in Sodium Alginate Based Sustainable Hydrogels for Environmental Applications10.1016/j.jclepro.2018.06.259 ↗
89. Piezoelectric Materials for Energy Harvesting and Sensing Applications: Roadmap for Future Smart Materials10.1002/advs.202100864 ↗
90. Cellulose Nanocrystals: Pretreatments, Preparation Strategies, and Surface Functionalization10.1016/j.ijbiomac.2021.05.119 ↗
91. Biointerface Structural Effects on the Properties and Applications of Bioinspired Peptide-Based Nanomaterials10.1021/acs.chemrev.7b00139 ↗